Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir.
Garrido, Carolina
Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir. [electronic resource] - AIDS (London, England) Mar 2012 - 551-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1473-5571
10.1097/QAD.0b013e3283509826 doi
ADP-ribosyl Cyclase 1--drug effects
Adult
Antiretroviral Therapy, Highly Active--methods
CD4 Lymphocyte Count
Case-Control Studies
Fas Ligand Protein--drug effects
Flow Cytometry
HIV Infections--drug therapy
HIV Integrase Inhibitors--therapeutic use
Humans
Leukocyte Common Antigens--drug effects
Middle Aged
Platelet Endothelial Cell Adhesion Molecule-1--drug effects
Pyrrolidinones--therapeutic use
Raltegravir Potassium
TNF-Related Apoptosis-Inducing Ligand--drug effects
Treatment Outcome
Tumor Necrosis Factor Receptor Superfamily, Member 7--drug effects
Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir. [electronic resource] - AIDS (London, England) Mar 2012 - 551-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1473-5571
10.1097/QAD.0b013e3283509826 doi
ADP-ribosyl Cyclase 1--drug effects
Adult
Antiretroviral Therapy, Highly Active--methods
CD4 Lymphocyte Count
Case-Control Studies
Fas Ligand Protein--drug effects
Flow Cytometry
HIV Infections--drug therapy
HIV Integrase Inhibitors--therapeutic use
Humans
Leukocyte Common Antigens--drug effects
Middle Aged
Platelet Endothelial Cell Adhesion Molecule-1--drug effects
Pyrrolidinones--therapeutic use
Raltegravir Potassium
TNF-Related Apoptosis-Inducing Ligand--drug effects
Treatment Outcome
Tumor Necrosis Factor Receptor Superfamily, Member 7--drug effects